TOP NEWS By EDWARD WYATT Citigroup was accused of misleading investors in a $1 billion derivatives deal, then betting against them as the housing market in the United States began to show signs of distress. The Caucus By ADAM NAGOURNEY Gov. Rick Perry of Texas said he would propose a flat tax next week as part of a tax overhaul, signaling a new effort to separate himself from Mitt Romney. By KEITH BRADSHER The trade case accuses Chinese makers of "dumping" panels for less the cost of making them, and seeks tariffs of more than 100 percent of the wholesale import price. By BRIAN KNOWLTON and A new full-time envoy devoted to North Korean nuclear issues is expected to be appointed, and talks with Pyongyang are likely to resume soon, officials said. By GREG BISHOP and TIMOTHY WILLIAMS Officials say they killed at least 25 animals that escaped from an exotic animal preserve after the owner released the animals before killing himself. |
| Multimedia Huge protests in Athens as a two-day strike begins; the Mitt Romney and Rick Perry campaigns put the spin on Tuesday's heated debate; and the World Series begins Wednesday night. Opinion Room for Debate There's a common thread in the Occupy protests worldwide: everyone is mad. Do they have more in common than anger? |
BUSINESS By WILLIAM NEUMAN The outbreak, the deadliest incident of foodborne illness in the last 25 years, has been traced to Jensen Farms in Holly, Colo. DealBook By SUSANNE CRAIG Morgan Stanley, buoyed by solid performances in all its core divisions and a one-time accounting gain, announced third-quarter earnings of $2.15 billion, compared with a loss of $91 million a year ago. By CHRISTINE HAUSER The rising cost of gasoline helped push up the price index, but the pressure expected to ease in the months ahead. By JACK EWING, STEPHEN CASTLE AND RAPHAEL MINDER Key figures in addressing the debt crisis gathered under intense pressure to deliver a response, but tried to dampen expectations for a grand gesture. DealBook By MICHAEL J. DE LA MERCED By breaking off its research pharmaceutical business, Abbott Laboratories will follow a string of companies that have turned to corporate breakups to bolster shareholder value. |
ليست هناك تعليقات:
إرسال تعليق